Press releases

  2021/12/06 06:30AM
|

Quantum Genomics signs an exclusive license and production agreement with Gulf Pharmaceuticals Industries Julphar.

→ pdf
  2021/11/25 6:00PM
|

Quantum Genomics signs an exclusive license agreement with Teva Israel Ltd.

→ pdf
  2021/11/23 6:05PM
|

Dr. Catherine Llorens-Cortes receives the 2021 Emilia Valori Prize from the French Academy of Sciences

→ pdf
  2021/10/07 6:00PM
|

Quantum Genomics and its partners reach a new stage of development in Asia

→ pdf
  2021/10/06 6:00PM
|

Quantum Genomics Publishes 2021 Half-year Results and Reviews its Clinical Activity

→ pdf
  2021/08/27 10:45AM
|

Quantum Genomics Presents Results from Phase IIb QUORUM Study of Firibastat in Heart Failure at the European Society of Cardiology Meeting

→ pdf
  2021/07/08 08:00AM
|

Quantum Genomics Enrolls First Patient in Its Pivotal Phase III REFRESH Trial of Firibastat in Difficult-to-treat and Resistant Hypertension with Once-a-day Formulation of Firibastat.

→ pdf
  2021/07/05 08:00AM
|

Presentation of the Effects of QGC606 in an Experimental Model of Heart Failure at the Annual Congress of the European Society of Cardiology

→ pdf
  2021/06/28 6:00PM
|

QUORUM study : Results Announcement next August 27, 2021 at 10:30 am CEST

→ pdf
  2021/05/19 6:10PM
|

Quantum Genomics Announces the Publication of New Scientific Article in Biomedecine et Pharmacotherapy which further strengthen its Phase III development plan in difficult to treat and resistant hypertension

→ pdf
  2021/04/28 6:00PM
|

Quantum Genomics Secures 3 Million euros Non-dilutive Financing

→ pdf
  2021/04/21 08:00AM
|

Quantum Genomics will Present Top-line Results from its QUORUM study of Firibastat in Heart Failure post Myocardial Infarction at the European Society of Cardiology (ESC) Meeting

→ pdf
  2021/04/20 08:00AM
|

Quantum Genomics announces the end of its collaboration with Chinese Pharma Qilu in the development and commercialization of firibastat in China

→ pdf
  2021/03/25 6:00PM
|

Quantum Genomics Reports Full Year 2020 Operating and Financial Results

→ pdf
  2021/02/09 6:00PM
|

Orient EuroPharma Acquires Equity Stake in Quantum Genomics

→ pdf
  2021/01/18 08:00AM
|

Quantum Genomics Launches Phase III Pivotal REFRESH Study in Difficult-to-treat/Resistant Hypertension with Once-a-day Formulation of Firibastat

→ pdf

Each PDF has been scanned by antimalware and incorporates a SECURITY MASTER Footprint. To check its authenticity:
www.security-master-footprint.com

Party powered automatically by Actusnews Wire ©
(Primary Information Provider)